Genmab Stock Tumbles as Merus Deal Costs Cloud $896 Million Revenue Jump

Genmab A/S dropped roughly 10% in Copenhagen Friday, after the Danish biotech posted a steep first-quarter profit decline. Higher costs from its Merus deal and stepped-up R&D spending canceled out a healthy bump in revenue. Around midday CEST, shares were quoted at 1,586.25 Danish crowns, down 9.8%, Cboe Europe data showed on MarketScreener.

8 May 2026

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares slid on Wednesday, down about 3.3% at $30.44 in New York trading, as investors weighed a late-stage pipeline cut and the closing steps of a major acquisition. The Nasdaq-listed ADR touched $30.36 after opening at $31.42.

31 December 2025

NASDAQ:GMAB·NASDAQ:MRUS·Pharmaceuticals·Stock Market

Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout

Merus N.V. shares were halted on Tuesday after Nasdaq said the final merger step in Denmark’s Genmab’s $97-a-share cash acquisition closed before the market open, leaving the stock set for suspension on Dec. 31. Merus last traded around $90 late Monday, about 7% below its prior close, according to market data. NASDAQ Trader

30 December 2025

NASDAQ:GMAB·NASDAQ:MRUS·Stock Market

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout

TechStock² Updates

Marvell Shares Drop 10.3%, Wiping Out $22 Billion Amid Google Revenue Delay to 2029

Ambev Shares Slide 0.7%, 30 Million Shares Test 31.6% Margin Rebound

Coeur Mining Stock Falls 4.9%, Erasing $1.1 Billion as Metals Slide

B2Gold Reports Masbate Fatality After Stock Falls 2.9%; Production Continues

IREN Shares Drop 12.5% With $4 Billion AI Expansion Pushing Up Against $6.4 Billion Financing Hurdle

NVIDIA Sheds 4.6% and Loses $252 Billion in Value as Margin Concerns Emerge Over Memory Prices

SpaceX Shares Edge Up 0.5% with $1.86 Trillion Value as Quarterly Capex Hits $18.4 Billion

Intel Shares Drop 2.9%, Remain 5.8% Under $95 Offering as Company Delivers 25% Revenue Gain

PG&E Shares Drop 7.5%, Wiping Out $3 Billion After Delay to California Wildfire Shield

DraftKings Faces $67.6 Million Loss on $13.1 Billion U.S. Open Betting Volume

Investment Disclaimer